Received Jun 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 2051974 | OT |
No Adverse event; ROTATEQ was administered to 1 consumer following a temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. Pertinent medical history, concomitant medications and drug reactions/allergies were not reported. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 22-May-2025, the patient received the rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #2051974 expiration date: 16-Nov-2025 (dose was not reported), administered by oral route for prophylaxis following a temperature excursion of 18.8C for 9 hours and 20 minutes (product storage error). There was no previous temperature excursion. No adverse event was reported.